南宫NG28基因
About Henlius
Company Profile
Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
R&D Result
Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
Investor Relations
Information Disclosure
Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
Multi-media
Media Reports
Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
About Henlius
Company Profile
Corporate Culture
Honor
Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
R&D Result
Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
Investor Relations
Information Disclosure
Listing Documents
Announcement & Circulars
Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Event
Popular Science
Media Reports
Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
Technical Innovation Operational Excellence
Information Disclosure
Announcement & Circulars
Listing Documents
Corporate Governance
Board of Directors
Committees
Others
Reporting
Financial Reports
ESG Report
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Listing Documents
12 September 2019
ORANGE APPLICATION FORM
12 September 2019
BLUE APPLICATION FORM
12 September 2019
GREEN APPLICATION FORM
12 September 2019
YELLOW APPLICATION FORM
12 September 2019
WHITE APPLICATION FORM
12 September 2019
GLOBAL OFFERING(FORMAL NOTICE)
12 September 2019
GLOBAL OFFERING
23 December 2024
DOCUMENTS ON DISPLAY - PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS
